Pharma channel feed

Sanofi and As­traZeneca's RSV an­ti­body cuts hos­pi­tal­iza­tions by 83% in late-stage study, as $10B mar­ket bat­tle heats up

Last year

FDA signs off on Ot­su­ka, Lund­beck­'s an­tipsy­chot­ic for Alzheimer's ag­i­ta­tion

Last year
FDA+

Crush­ing their cat­e­gories? Physi­cians weigh in on phar­ma com­pa­nies by ther­a­py area

Last year
Marketing

House com­mit­tee holds hear­ing to iden­ti­fy root caus­es of re­cent drug short­ages

Last year
Manufacturing

Mer­ck tri­umphs in $1.4B cy­ber­at­tack ap­peals case

Last year

BioCryst de­buts print mag­a­zine for hered­i­tary an­gioede­ma pa­tients tak­ing Or­ladeyo

Last year
Marketing

AAV pro­duc­er New­Bi­ologix emerges from stealth with $50M Se­ries A

Last year
Cell/Gene Tx
Manufacturing

Sen­ate Fi­nance chair slams phar­ma in­dus­try's use of for­eign sub­sidiaries to cut their tax bills

Last year
Law

What's 'mean­ing­ful' phar­ma in­no­va­tion? House sub­com­mit­tee talks in­cen­tives

2 years ago

Teva's new CEO Richard Fran­cis is plan­ning a 'new chap­ter' for the gener­ics gi­ant

2 years ago

In­sulin prices in the Sen­ate hot seat: PBM and phar­ma fin­ger-point­ing con­tin­ues as land­scape shifts

2 years ago

FDA ad­comm votes unan­i­mous­ly in fa­vor of ben­e­fit-risk pro­file of over-the-counter con­tra­cep­tive Opill

2 years ago

‘Phar­ma Bro’ Mar­tin Shkre­li's com­pa­nies file for bank­rupt­cy

2 years ago
Law

Stop the mu­sic: Pub­lic health ad­vo­cates join fight to ban ‘dis­trac­tion tech­nique’ in drug ads

2 years ago
Marketing

When or­phan drugs are block­busters: Re­searchers call on Con­gress to make com­pa­nies pay back tax cred­its

3 years ago
R&D

As­traZeneca block­buster Farx­i­ga adds new heart in­di­ca­tion to la­bel

3 years ago
FDA+

Gilead wins US patent tri­al over HIV pre­ven­tion drugs

3 years ago
Law

Af­ter warn­ing let­ters and fa­tal poi­son­ings, FDA is­sues guid­ance for strin­gent test­ing of con­t­a­m­i­nants

3 years ago
FDA+
Manufacturing

Roche, Mer­ck and Pfiz­er lead US phar­ma cor­po­rate rep­u­ta­tion rank­ing by pa­tient groups

3 years ago
Marketing

Bris­tol My­ers Squibb lays off 48 in New Jer­sey

3 years ago
People

Abor­tion providers sue FDA in a Vir­ginia fed­er­al court over mifepri­s­tone re­stric­tions

3 years ago

Mar­ket­ingRx roundup: Ab­b­Vie de­buts Vray­lar cam­paign for de­pres­sion; Amy­lyx re-ups “Get Inked” for ALS ef­fort

3 years ago
Marketing

Tar­sus is­sues 'call to ac­tion' months be­fore FDA de­ci­sion on eye mite treat­ment

3 years ago
Marketing

Up­dat­ed: EQRx aban­dons its mis­sion of drug price re­form, will cut more than half of em­ploy­ees

3 years ago
R&D
First page Previous page 123124125126127128129 Next page Last page
A service from the Financial Times